Medullary thyroid carcinoma (MTC) is one of the most challenging cancers.
Epidemiological studies have shown that during the past 30 years neither a change in stage at diagnosis nor a significant improvement in survival has been achieved.
Therefore, new diagnostic and therapeutic strategies are needed for early detection of metastases or disease recurrence and tumor growth control.

doi.org/10.20452/pamw.4387, hdl.handle.net/1765/113461
Polskie Archiwum Medycyny Wewnetrznej
Department of Radiology

Erba, P, Mäcke, H.R, Mikolajczak, R, Decristoforo, C, Zaletel, K, Maina-Nock, T. (Theodosia), … Hubalewska-Dydejczyk, A. (2017). A novel CCK2/gastrin receptor-localizing radiolabeled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid carcinoma. Polskie Archiwum Medycyny Wewnetrznej, 128(12). doi:10.20452/pamw.4387